{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:07:48Z","timestamp":1759410468507},"reference-count":27,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.01.072","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T11:33:02Z","timestamp":1328268782000},"page":"2421-2426","source":"Crossref","is-referenced-by-count":6,"title":["A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination\u2014Possible stimulated reporting?"],"prefix":"10.1016","volume":"30","author":[{"given":"Michael M.","family":"McNeil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Arana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brock","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Hartshorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hrncir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lamias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Stamper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome I.","family":"Tokars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata J.","family":"Engler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.01.072_bib0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0010","series-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2010"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0015","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2008.10.006","article-title":"A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"26","author":"Gidudu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","article-title":"Reassessment of the association between Guillain-Barr\u00e9 syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study. Expert Neurology Group","volume":"133","author":"Safranek","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.01.072_bib0030","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.01.072_bib0035","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1542\/peds.2010-1722L","article-title":"Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program","volume":"127","author":"Salmon","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0040","unstructured":"Federal Immunization Safety Task Force. Federal Plans to Monitor Immunization Safety for the Pandemic 2009 H1N1 Influenza Vaccination Program. Accessed 6 June 2011 at: http:\/\/www.flu.gov\/professional\/federal\/monitor_immunization_safety.html."},{"key":"10.1016\/j.vaccine.2012.01.072_bib0045","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","article-title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009\u2013January 31, 2010","volume":"28","author":"Vellozzi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0050","doi-asserted-by":"crossref","unstructured":"Assistant Secretary for Defense (Reserve Affairs) Memorandum: Department of Defense Pandemic Vaccine Guidance for 2009 H1N1 Pandemic. Washington, DC; 2009.","DOI":"10.21236\/ADA512950"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0055","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) \u2013 United States 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/pds.1349","article-title":"Comparison of military and civilian reporting rates for smallpox vaccine adverse events","volume":"16","author":"McMahon","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0065","series-title":"Defense Health Care: DoD needs to improve force health protection and surveillance processes","author":"US General Accounting Office","year":"2003"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4161\/hv.4.4.5802","article-title":"Attitudes towards vaccines and infectious disease risk among US troops","volume":"4","author":"Porter","year":"2008","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1708-8305.2007.00173.x","article-title":"Attitudes toward predeployment and experimental vaccinations among troops deployed to operation Iraqi Freedom and Operation Enduring Freedom","volume":"15","author":"Riddle","year":"2008","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4161\/hv.5.11.9870","article-title":"Cross-sectional survey of anthrax vaccine coverage and KAP among deployed US military","volume":"5","author":"Porter","year":"2009","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7205\/MILMED.173.5.429","article-title":"US military service members\u2019 perceptions of Anthrax Vaccine Immunization Program","volume":"173","author":"Pica-Branco","year":"2008","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0090","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4161\/hv.7.7.15574","article-title":"Pre-deployment vaccinations and perception of risk among US military personnel","volume":"7","author":"Polak","year":"2011","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0095","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4161\/hv.8476","article-title":"Sex differences in injection site reactions with human vaccines","volume":"5","author":"Cook","year":"2009","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01586187","article-title":"Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies","volume":"15","author":"Beyer","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0110","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/S0264-410X(02)00172-X","article-title":"Aluminum-containing vaccine associated adverse events: role of route of administration and gender","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0120","first-page":"764","article-title":"Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan","volume":"79","author":"Kharabsheh","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00002018-200326090-00001","article-title":"Mass psychogenic illness after vaccination","volume":"26","author":"Clements","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.15.21.19575-en","article-title":"Mass psychogenic illness in nationwide in-school vaccination for pandemic influenza A (H1N1) 2009, Taiwan, November 2009\u2013January 2010","volume":"15","author":"Huang","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2012.01.072_bib0135","series-title":"Manual for the Surveillance of Vaccine Preventable Diseases, 2008\u20132009","article-title":"Surveillance for adverse events following immunization using the Vaccine Adverse Event Reporting System (VAERS)","author":"Miller","year":"2011"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T20:17:45Z","timestamp":1640636265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12001107"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}